VAXREX Trademark

Trademark Overview

On Wednesday, March 10, 2021, a trademark application was filed for VAXREX with the United States Patent and Trademark Office. The USPTO has given the VAXREX trademark a serial number of 90570605. The federal status of this trademark filing is REGISTERED as of Tuesday, September 17, 2024. This trademark is owned by Metaclipse Therapeutics Corporation. The VAXREX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the prevention of viral diseases and disorders; human vaccine preparations; vaccines; pharmaceutical preparations for the prevention of a COVID-19 infection
vaxrex

General Information

Serial Number90570605
Word MarkVAXREX
Filing DateWednesday, March 10, 2021
Status700 - REGISTERED
Status DateTuesday, September 17, 2024
Registration Number7508054
Registration DateTuesday, September 17, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 16, 2021

Trademark Statements

Goods and Servicespharmaceutical preparations for the prevention of viral diseases and disorders; human vaccine preparations; vaccines; pharmaceutical preparations for the prevention of a COVID-19 infection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 10, 2021
Primary Code005
First Use Anywhere DateWednesday, July 12, 2023
First Use In Commerce DateWednesday, July 12, 2023

Trademark Owner History

Party NameMetaclipse Therapeutics Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30340
Party NameMetaclipse Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30340
Party NameMetaclipse Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30340

Trademark Events

Event DateEvent Description
Saturday, March 13, 2021NEW APPLICATION ENTERED
Thursday, June 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 4, 2021ASSIGNED TO EXAMINER
Tuesday, October 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 11, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 8, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 8, 2022SOU EXTENSION 1 FILED
Friday, July 8, 2022SOU EXTENSION 1 GRANTED
Tuesday, July 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 11, 2023SOU EXTENSION 2 FILED
Wednesday, January 11, 2023SOU EXTENSION 2 GRANTED
Tuesday, July 11, 2023SOU TEAS EXTENSION RECEIVED
Friday, January 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 11, 2023SOU EXTENSION 3 FILED
Tuesday, July 11, 2023SOU EXTENSION 3 GRANTED
Thursday, July 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 11, 2024SOU EXTENSION 4 FILED
Friday, January 12, 2024TEAS STATEMENT OF USE RECEIVED
Friday, January 12, 2024USE AMENDMENT FILED
Saturday, February 3, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 5, 2024SOU EXTENSION 4 GRANTED
Monday, February 5, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, August 12, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 12, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 17, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 17, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

vaxrex preparations pharmaceutical prevention vaccines infection vaccine covid disorders viral diseases